Interfor Announces Incremental Lumber Production Curtailments for the Fourth Quarter of 2025

(TSX:IFP), BURNABY, B.C., Oct. 17, 2025 (GLOBE NEWSWIRE) — INTERFOR CORPORATION (“Interfor” or the “Company”) (TSX: IFP) announced today revised operating plans for the fourth quarter of 2025. Due to persistently weak market conditions and ongoing economic uncertainty, Interfor will further temporarily reduce lumber production across its operations in British Columbia, Ontario, the US Pacific […]

Interfor Announces Incremental Lumber Production Curtailments for the Fourth Quarter of 2025

Interfor Announces Incremental Lumber Production Curtailments for the Fourth Quarter of 2025 GlobeNewswire October 17, 2025 BURNABY, B.C., Oct. 17, 2025 (GLOBE NEWSWIRE) — INTERFOR CORPORATION (“Interfor” or the “Company”) (TSX: IFP) announced today revised operating plans for the fourth quarter of 2025. Due to persistently weak market conditions and ongoing economic uncertainty, Interfor will

InfraSight and Former CME Board Member Launch Industry’s First Compute Yield Index

CHARLOTTE, N.C. and CHICAGO, Oct. 17, 2025 (GLOBE NEWSWIRE) — Global compute spending is on pace to reach an estimated $6.7 trillion in cumulative spend by 2030, surpassing oil in economic magnitude. At this scale, the absence of standardized benchmarks creates systemic risk. Without yield curves or pricing transparency, enterprises can't benchmark efficiency, investors can't

InfraSight and Former CME Board Member Launch Industry’s First Compute Yield Index

InfraSight and Former CME Board Member Launch Industry's First Compute Yield Index Infra(TM) Yield Index (IYI) establishes the industry benchmark for compute yield, enabling the C-Suite to track their compute efficiency against market consensus, optimize procurement decisions, and prepare for yield-based hedging instruments GlobeNewswire October 17, 2025 CHARLOTTE, N.C. and CHICAGO, Oct. 17, 2025 (GLOBE

Autoliv: Financial Report July – September 2025

Q3 2025: Record 3rd quarter sales, operating income and EPS Financial highlights Q3 2025 $2,706 million net sales 5.9%net sales increase 3.9% organic sales growth* 9.9%operating margin 10.0%adjusted operating margin* $2.28 dilutedEPS, 31% increase $2.32 adjusted diluted EPS*, 26% increase Full year 2025 guidance Around 3%organic sales growth Around 1%FX effect on net sales Around

UCLOUDLINK GROUP INC. Announces Plan to Establish New Operational Structure for Its Pet-Tech Business

(NasdaqGM:UCL), HONG KONG, Oct. 17, 2025 (GLOBE NEWSWIRE) — UCLOUDLINK GROUP INC. (NASDAQ: UCL) (“UCLOUDLINK” or the “Company”), the world's first and leading mobile data traffic sharing marketplace, today announced that its board of directors has approved a plan to operate its pet-tech business under a new operational structure. The initiative will incorporate a new

UCLOUDLINK GROUP INC. Announces Plan to Establish New Operational Structure for Its Pet-Tech Business

UCLOUDLINK GROUP INC. Announces Plan to Establish New Operational Structure for Its Pet-Tech Business GlobeNewswire October 17, 2025 HONG KONG, Oct. 17, 2025 (GLOBE NEWSWIRE) — UCLOUDLINK GROUP INC. (NASDAQ: UCL) (“UCLOUDLINK” or the “Company”), the world's first and leading mobile data traffic sharing marketplace, today announced that its board of directors has approved a

SVRA ALERT: Securities Fraud Class Action Launched Against Savara Inc. – November 7, 2025 Deadline

NEW YORK CITY, NY / ACCESS Newswire / October 17, 2025 / NEW YORK, NY / ACCESS Newswire / October 17, 2025 / If you suffered a loss on your Savara Inc. (NASDAQ:SVRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/savara-inc-lawsuit-submission-form?prid=172682&wire=1&utm_campaign=26

ATTENTION MLTX Shareholders: Lost Money on MoonLake Immunotherapeutics? Contact Levi & Korsinsky About Investigation

NEW YORK CITY, NY / ACCESS Newswire / October 17, 2025 / NEW YORK, NY / ACCESS Newswire / October 17, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of MoonLake Immunotherapeutics ("MoonLake") (NASDAQ:MLTX) concerning possible violations of federal securities laws. On September 29, 2025, MoonLake announced that its experimental

Scroll to Top